本页面由Tiger Trade Technology Pte. Ltd.提供服务

Edgewise Therapeutics, Inc.

34.43
+1.313.96%
盘后34.28-0.1455-0.42%17:48 EDT
成交量:82.40万
成交额:2,818.14万
市值:36.93亿
市盈率:-21.12
高:35.00
开:33.67
低:33.15
收:33.12
52周最高:35.00
52周最低:12.15
股本:1.07亿
流通股本:6,084.98万
量比:1.01
换手率:1.35%
股息:- -
股息率:- -
每股收益(TTM):-1.6302
每股收益(LYR):-1.6302
净资产收益率:-34.19%
总资产收益率:-23.02%
市净率:7.07
市盈率(LYR):-21.12

数据加载中...

2024/02/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/01

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/29

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/26

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/26

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/19

重要事件披露

Form 8-K - Current report
2024/01/19

重要事件披露

Form 8-K - Current report
2023/12/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/09

重要事件披露

Form 8-K - Current report
2023/08/10

重要事件披露

Form 8-K - Current report
2023/08/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/07/15

重要事件披露

Form 8-K - Current report
2023/06/29

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/06/22

重要事件披露

Form 8-K - Current report
2023/06/17

重要事件披露

Form 8-K - Current report
2023/06/12

重要事件披露

Form 8-K - Current report